Clinical Trials Logo

Bone Tumors clinical trials

View clinical trials related to Bone Tumors.

Filter by:
  • None
  • Page 1

NCT ID: NCT05475938 Completed - Bone Tumors Clinical Trials

Application of Painting Analysis and Psychotherapy in Children With Bone Tumors

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

In the population suffering from cancer, children and teenagers are in the majority. For children with rapid development of body and mind, with the change of cognitive ability, they will feel anxiety and fear about the expected potential negative events. Painting art therapy is a kind of non-verbal psychological therapy through the interaction between the painter, the painting work and the therapist, with the painting creation activity as the intermediary. The purpose is to develop symbolic language, touch the inner subconscious, and integrate into the personality, so as to produce cognitive and behavioral changes. Painting therapy and psychological analysis can improve the treatment compliance of children bone tumor patients, make psychological nursing and health education of patients more targeted, and promote the cooperation between medical care and patients.

NCT ID: NCT05131386 Recruiting - Soft Tissue Sarcoma Clinical Trials

Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas

SYNERGIAS
Start date: May 28, 2021
Phase: Phase 2
Study type: Interventional

Phase II, multicohort, single arm, open-label, multicenter, international clinical trial with three cohorts (cohort A: Soft tissue sarcoma, cohort B: Bone tumors (osteosarcoma, chondrosarcoma and cohort C: Small round-cell sarcomas (Ewing's sarcoma, rhabdomyosarcoma, desmoplastic small round-cell tumors and other small round cell sarcomas)) with 7 sites in Spain. Main objective: To evaluate the overall response rate (ORR) in the irradiated nodules according to RECIST v1.1 criteria. Treatment Medication Trabectedin at 1.5 mg/m2 24-h IV CI along with radiation therapy (30 Gy, 3 Gy/day for 10 days for non-extremity location and 45 Gy, 1.8 Gy/day for 25 days for extremity location of target lesion(s)), starting within 1 hour after the first trabectedin infusion withdrawal (day 2)) will be given every 3 weeks up to progression or intolerance. Premedication 4 mg oral dexamethasone 24h and 12h before trabectedin administration, 20 mg IV dexamethasone 30 minutes before treatment. Ondansetron or analogue will also be given prior to trabectedin.

NCT ID: NCT02901782 Completed - Bone Tumors Clinical Trials

The Application of Personalized Titanium Plate in the Bone Tumors Around the Knee

Start date: January 2013
Phase: N/A
Study type: Interventional

Microwave ablation of bone tumors is time-consuming and usually results in postoperative fractures. Hence the investigators designed and fabricated a titanium plate customized to the patient's bone structures for fixation after the removal of tumorous tissue, to improve the clinical outcomes of microwave ablation.

NCT ID: NCT02109952 Active, not recruiting - Bone Tumors Clinical Trials

Biomechanics of Metastatic Defects in Bone

Start date: January 2009
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to monitor fracture risk associated with bone tumors in cancer patients. Previous studies from our lab have suggested that it is possible to compute the mechanical strength of bones with tumors using computed tomography (CT) scans, which are like three-dimensional X-ray pictures of the affected bones. The next step in determining the usefulness of this type of strength analysis is to see if we can accurately predict who is at risk for bone fracture and which patients are at high risk of fractures. This non-invasive analysis may help physicians determine the best treatment to reduce the risk of an impending bone fracture in the future.

NCT ID: NCT01304121 Completed - Bone Tumors Clinical Trials

Bioactive Glass Granules in Filling of Bone Defects

Start date: October 2006
Phase: Phase 4
Study type: Interventional

This is a randomized clinical trial that will be carried out to examine the use of bioactive glass granules (S53P4) as bone graft substitute in filling small and large bone defects as compared with autogenous and allogeneic bone grafting, respectively.

NCT ID: NCT01179698 Recruiting - Bone Tumors Clinical Trials

Navigation Surgery for Bone and Soft Tissue Tumor

Start date: January 2009
Phase: N/A
Study type: Interventional

Bone tumor near the articular cartilage is hard to remove sufficiently without damaging adjacent joint. The purpose of this study was to evaluate the feasibility of navigation-assisted surgery for saving joint in bone tumor resection or curettage. In this study, the investigators hypothesized that computer-assisted surgery is feasible method to get both enough margin and joint salvage. Each of them is important intermediate factor for either oncologic outcome or functional outcome respectively. The investigators designed this study to find what proportion of patients who underwent computer-assisted resection could get enough margins using some criteria obtained by overlapping preoperative and postoperative images. The investigators also evaluated whether computer-assisted surgery can be feasible for joint saving using some criteria including functional outcome.

NCT ID: NCT00594776 Completed - Bone Tumors Clinical Trials

Vascular CT Assessment of Structural Autograft and Allograft Healing

Start date: November 2006
Phase: N/A
Study type: Observational

The purpose of this study is to determine the ability of a cone beam CT to measure bone healing.